Dynavax Technologies Corporation (DVAX)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	27,309	20,478	17,177	9,222	-6,389	61,125	110,641	235,965	293,025	325,071	232,832	108,217	76,310	-38,936	-6,105	-61,824	-75,240	-96,529	-134,389	-125,523
Revenue (ttm)	US$ in thousands	277,247	260,811	249,695	236,149	232,284	361,180	459,401	655,616	722,683	733,261	673,796	470,099	439,442	263,922	169,066	118,967	46,551	37,571	34,732	40,365
Net profit margin		9.85%	7.85%	6.88%	3.91%	-2.75%	16.92%	24.08%	35.99%	40.55%	44.33%	34.56%	23.02%	17.37%	-14.75%	-3.61%	-51.97%	-161.63%	-256.92%	-386.93%	-310.97%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $27,309K ÷ $277,247K
= 9.85%

Dynavax Technologies Corporation's net profit margin has shown a significant improvement over the past few years based on the given data. The company experienced negative net profit margins in the range of -310.97% to -161.63% in early 2020, reflecting significant losses compared to its revenue during that period.

However, there was a turnaround in the company's performance starting from March 31, 2021, when the net profit margin began to improve, albeit still negative at -51.97%. The trend continued to show gradual enhancement, with the net profit margin reaching positive territory by December 31, 2021, and increasing substantially to 44.33% by September 30, 2022.

From December 31, 2022, to June 30, 2024, Dynavax Technologies Corporation's net profit margin consistently stayed positive, demonstrating the company's ability to generate profits relative to its revenue. The net profit margins improved from 40.55% on December 31, 2022, to 9.85% on December 31, 2024, indicating a favorable trend in the company's profitability.

Overall, the positive trajectory of Dynavax Technologies Corporation's net profit margin in recent years suggests improvements in the company's cost management, revenue generation, and overall profitability.